0HS8:LSE:LSE-Caladrius Biosciences Inc. (USD)

COMMON STOCK | |

Last Closing

USD 3.0121

Change

0.00 (0.00)%

Market Cap

N/A

Volume

479.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
0R2T:LSE Micron Technology Inc

-4.41 (-4.94%)

USD 9,223,372,036.85B
0R37:LSE Berkshire Hathaway Inc

-6.25 (-1.36%)

USD 9,223,372,036.85B
0R2F:LSE Wells Fargo & Company

-1.28 (-1.78%)

USD 9,223,372,036.85B
0R2V:LSE Apple Inc.

+9.00 (+3.65%)

USD 9,223,372,036.85B
0R15:LSE SoftBank Group Corp.

+300.99 (+3.39%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+93.00 (+1.01%)

USD 7,596.04B
0M69:LSE OTP Bank Nyrt

N/A

USD 5,014.80B
0R28:LSE Newmont Corp.

-0.13 (-0.34%)

USD 4,231.43B
0R2O:LSE Freeport-McMoRan Inc.

-0.47 (-1.21%)

USD 4,154.37B
0QY4:LSE Las Vegas Sands Corp.

-0.85 (-1.64%)

USD 4,148.69B

ETFs Containing 0HS8:LSE

EATZ AdvisorShares Restaurant .. 5.34 % 0.00 %

-0.23 (-0.81%)

USD 3.47M
HAU-U:CA 3.45 % 0.00 %

N/A

N/A
BTAL AGFiQ U.S. Market Neutral.. 0.43 % 0.00 %

-0.59 (-0.81%)

N/A
XDEW:LSE Xtrackers S&P 500 Equal W.. 0.23 % 0.00 %

-1.07 (-0.81%)

N/A
XDWE:LSE Xtrackers (IE) Public Lim.. 0.23 % 0.00 %

-37.50 (-0.81%)

N/A
RXI iShares Global Consumer D.. 0.00 % 0.46 %

-2.81 (-0.81%)

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.76% N/A N/A 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.76% N/A N/A 53% F
Trailing 12 Months  
Capital Gain 5.76% N/A N/A 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.76% N/A N/A 53% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 115.71% N/A N/A 95% A
Dividend Return 115.71% N/A N/A 95% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 208.81% N/A N/A 10% F
Risk Adjusted Return 55.41% N/A N/A 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike